Coho Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-183,148
| Closed | -$57.1M | – | 35 |
|
|
2025
Q1 | $57.1M | Sell |
183,148
-76,280
| -29% | -$22.5M | 3.44% | 16 |
|
|
2024
Q4 | $67.6M | Sell |
259,428
-91,817
| -26% | -$27.2M | 3.11% | 18 |
|
|
2024
Q3 | $113M | Sell |
351,245
-45,383
| -11% | -$14.8M | 4.13% | 8 |
|
|
2024
Q2 | $124M | Sell |
396,628
-60,014
| -13% | -$17.6M | 4.32% | 6 |
|
|
2024
Q1 | $130M | Sell |
456,642
-47,777
| -9% | -$14M | 3.19% | 18 |
|
|
2023
Q4 | $145M | Sell |
504,419
-105,319
| -17% | -$28.7M | 3.38% | 15 |
|
|
2023
Q3 | $164M | Sell |
609,738
-62,175
| -9% | -$15.5M | 3.49% | 13 |
|
|
2023
Q2 | $149M | Sell |
671,913
-29,243
| -4% | -$6.79M | 2.71% | 20 |
|
|
2023
Q1 | $170M | Sell |
701,156
-8,955
| -1% | -$2.2M | 2.93% | 20 |
|
|
2022
Q4 | $187M | Sell |
710,111
-109,303
| -13% | -$29.3M | 3.16% | 19 |
|
|
2022
Q3 | $185M | Buy |
819,414
+30,829
| +4% | +$7.47M | 3.47% | 13 |
|
|
2022
Q2 | $192M | Sell |
788,585
-37,717
| -5% | -$9.24M | 3.58% | 10 |
|
|
2022
Q1 | $200M | Buy |
826,302
+85,352
| +12% | +$19.6M | 3.29% | 18 |
|
|
2021
Q4 | $167M | Sell |
740,950
-54,488
| -7% | -$11.5M | 2.62% | 19 |
|
|
2021
Q3 | $169M | Sell |
795,438
-167,752
| -17% | -$38.6M | 2.74% | 20 |
|
|
2021
Q2 | $235M | Sell |
963,190
-8,761
| -0.9% | -$2.16M | 3.68% | 11 |
|
|
2021
Q1 | $242M | Sell |
971,951
-11,869
| -1% | -$2.83M | 3.93% | 8 |
|
|
2020
Q4 | $226M | Buy |
983,820
+69,101
| +8% | +$15.9M | 3.92% | 8 |
|
|
2020
Q3 | $232M | Sell |
914,719
-159,002
| -15% | -$39.4M | 4.75% | 3 |
|
|
2020
Q2 | $253M | Buy |
1,073,721
+6,505
| +0.6% | +$1.48M | 5.5% | 1 |
|
|
2020
Q1 | $216M | Sell |
1,067,216
-22,899
| -2% | -$5M | 5.55% | 1 |
|
|
2019
Q4 | $263M | Buy |
1,090,115
+17,787
| +2% | +$3.92M | 5.39% | 1 |
|
|
2019
Q3 | $208M | Sell |
1,072,328
-36,981
| -3% | -$7.1M | 4.9% | 1 |
|
|
2019
Q2 | $204M | Sell |
1,109,309
-30,489
| -3% | -$5.46M | 4.8% | 2 |
|
|
2019
Q1 | $217M | Buy |
1,139,798
+26,772
| +2% | +$5.11M | 4.89% | 1 |
|
|
2018
Q4 | $217M | Buy |
1,113,026
+45,621
| +4% | +$8.9M | 5.49% | 1 |
|
|
2018
Q3 | $221M | Sell |
1,067,405
-26,904
| -2% | -$5.3M | 5.25% | 1 |
|
|
2018
Q2 | $202M | Buy |
1,094,309
+31,312
| +3% | +$5.54M | 4.97% | 2 |
|
|
2018
Q1 | $181M | Buy |
1,062,997
+128,697
| +14% | +$23.6M | 4.76% | 2 |
|
|
2017
Q4 | $162M | Sell |
934,300
-33,570
| -3% | -$5.94M | 4.02% | 10 |
|
|
2017
Q3 | $180M | Sell |
967,870
-66,781
| -6% | -$11.8M | 4.63% | 7 |
|
|
2017
Q2 | $178M | Buy |
1,034,651
+212,213
| +26% | +$34.5M | 4.45% | 6 |
|
|
2017
Q1 | $135M | Buy |
822,438
+33,110
| +4% | +$5.5M | 4.39% | 7 |
|
|
2016
Q4 | $115M | Buy |
789,328
+16,833
| +2% | +$2.53M | 4.02% | 10 |
|
|
2016
Q3 | $129M | Buy |
772,495
+8,877
| +1% | +$1.5M | 4.63% | 2 |
|
|
2016
Q2 | $116M | Buy |
763,618
+61,005
| +9% | +$9.48M | 4.22% | 8 |
|
|
2016
Q1 | $105M | Buy |
702,613
+27,949
| +4% | +$4.15M | 4.35% | 7 |
|
|
2015
Q4 | $110M | Buy |
674,664
+10,089
| +2% | +$1.59M | 4.84% | 1 |
|
|
2015
Q3 | $91.9M | Buy |
664,575
+90,913
| +16% | +$14.3M | 4.37% | 4 |
|
|
2015
Q2 | $88.1M | Buy |
573,662
+109,597
| +24% | +$17.6M | 4.62% | 3 |
|
|
2015
Q1 | $74.2M | Buy |
464,065
+46,061
| +11% | +$7.25M | 3.81% | 11 |
|
|
2014
Q4 | $66.6M | Buy |
418,004
+22,083
| +6% | +$3.44M | 3.77% | 14 |
|
|
2014
Q3 | $55.6M | Sell |
395,921
-116,313
| -23% | -$15.2M | 3.55% | 19 |
|
|
2014
Q2 | $60.6M | Buy |
512,234
+31,022
| +6% | +$3.59M | 4.09% | 9 |
|
|
2014
Q1 | $59.4M | Buy |
481,212
+39,665
| +9% | +$4.81M | 4.39% | 6 |
|
|
2013
Q4 | $50.4M | Buy |
441,547
+2,915
| +0.7% | +$332K | 4.25% | 8 |
|
|
2013
Q3 | $49.1M | Buy |
438,632
+15,089
| +4% | +$1.64M | 4.52% | 5 |
|
|
2013
Q2 | $41.8M | Buy |
+423,543
| New | +$44M | 4.17% | 7 |
|
Other funds holding AMGN
Coho Partners's AMGN Position: Q2 2025 in Review
Coho Partners sold out of Amgen (AMGN) in Q2 2025, closing a stake of 183,148 shares — an estimated $57.1M sold.
Coho Partners first reported a position in AMGN in Q2 2013 and held it in 48 quarters. The position peaked at $263M in Q4 2019. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- Coho Partners reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
- Coho Partners sold 183,148 Amgen shares in Q2 2025, an estimated $57.1M.
- Coho Partners first reported a position in Amgen in Q2 2013 and held it in 48 quarters.
- Coho Partners's Amgen position peaked at $263M in Q4 2019.
- 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on Coho Partners's 13F filing for Q2 2025, filed 29 Jul 2025.